Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Alexis Boaz

ID: 1b831884-2619-30fb-68c4

/

Unclaimed

/

Organization: Epstein Becker & Green, P.C.

CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates

Health Care and Life Sciences · September 1, 2023

Texas Federal Court Issues Fourth Ruling Invalidating Parts of the Administration’s No Surprises Act Regulations

Health Care and Life Sciences · August 30, 2023

Independent Dispute Resolution Process Halted Following the Government’s Third Major No Surprises Act-Related Loss in Federal Court

Health Care and Life Sciences · August 14, 2023

TAKE TWO: CMS’s Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year

Health Care and Life Sciences · July 21, 2023

More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate

Health Care and Life Sciences · May 22, 2023

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog